What question did this study set out to answer?

The aim is to explore how OGT deficiency affects cognitive decline related to diabetes and evaluate semaglutide as a treatment.

April 16, 2026Diabetes Obesity and Metabolism0 citations

View Full Paper

OGT Ameliorates Diabetes‐Associated Cognitive Decline via Modulation of DRP1 Function and Mitochondrial Homeostasis

TLT Li XDXiaoqing Deng YMYahui Miao

Key Points

The aim is to explore how OGT deficiency affects cognitive decline related to diabetes and evaluate semaglutide as a treatment.
Evaluation of OGT deficiency and its impact on mitochondrial function.
Assessment of cognitive performance related to diabetes.
Analysis of semaglutide's effect on mitochondrial homeostasis and cognitive outcomes.
OGT deficiency leads to imbalanced mitochondrial function contributing to cognitive decline.
Semaglutide shows potential in protective effects on OGT functions.
Modulation of DRP1 activity is linked to improved cognitive health.

Abstract

OGT deficiency-mediated mitochondrial homeostasis imbalance contributes to the occurrence of DACD, and semaglutide with an OGT protective effect may be a potential therapeutic approach for DACD.

问 AI

Bookmark

View Full Paper

Cite This Study

Li et al. (Tue,) studied this question.

synapsesocial.com/papers/69e07de52f7e8953b7cbee83 https://doi.org/https://doi.org/10.1111/dom.70758

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

问 AI

Bookmark

View Full Paper